Rockwell Medical (NASDAQ:RMTI) Earns "Buy" Rating from HC Wainwright

Rockwell Medical (NASDAQ:RMTI - Get Free Report)'s stock had its "buy" rating restated by stock analysts at HC Wainwright in a research note issued to investors on Monday,Benzinga reports. They presently have a $7.00 target price on the stock. HC Wainwright's target price suggests a potential upside of 231.75% from the company's previous close.

A number of other research firms also recently commented on RMTI. StockNews.com downgraded shares of Rockwell Medical from a "buy" rating to a "hold" rating in a research report on Friday. RODMAN&RENSHAW raised Rockwell Medical to a "strong-buy" rating in a research report on Thursday, November 14th. Finally, Rodman & Renshaw assumed coverage on Rockwell Medical in a report on Thursday, November 14th. They issued a "buy" rating and a $5.00 price objective for the company.

Rockwell Medical Stock Up 1.4 %

RMTI stock traded up $0.03 during trading on Monday, hitting $2.11. 402,884 shares of the company's stock were exchanged, compared to its average volume of 398,339. The stock has a market capitalization of $68.19 million, a price-to-earnings ratio of -42.20 and a beta of 1.38. Rockwell Medical has a 52-week low of $1.16 and a 52-week high of $5.15. The company has a current ratio of 2.41, a quick ratio of 2.00 and a debt-to-equity ratio of 0.33. The business has a 50-day moving average price of $2.86 and a two-hundred day moving average price of $2.71.

Institutional Trading of Rockwell Medical

Hedge funds have recently added to or reduced their stakes in the stock. Armistice Capital LLC raised its stake in shares of Rockwell Medical by 22.5% during the second quarter. Armistice Capital LLC now owns 3,221,640 shares of the company's stock worth $5,670,000 after purchasing an additional 592,000 shares during the last quarter. XTX Topco Ltd increased its stake in Rockwell Medical by 45.7% in the 3rd quarter. XTX Topco Ltd now owns 28,455 shares of the company's stock valued at $113,000 after buying an additional 8,922 shares during the period. Renaissance Technologies LLC raised its position in Rockwell Medical by 877.1% during the 2nd quarter. Renaissance Technologies LLC now owns 102,700 shares of the company's stock worth $181,000 after buying an additional 92,189 shares during the last quarter. Beacon Financial Advisory LLC acquired a new stake in shares of Rockwell Medical in the 3rd quarter worth $98,000. Finally, Walleye Capital LLC purchased a new stake in shares of Rockwell Medical in the third quarter valued at about $435,000. 23.31% of the stock is owned by institutional investors and hedge funds.

Rockwell Medical Company Profile

Rockwell Medical, Inc, together with its subsidiaries, operates as a healthcare company that engages in the development, manufacture, commercialization, and distribution of various hemodialysis products for dialysis providers worldwide. The company offers Triferic Dialysate and Triferic AVNU which are indicated to maintain hemoglobin in adult undergoing hemodialysis.